Study on isoflavones isomers contents in Taiwan's soybean and GM soybean

Journal of Food and Drug Analysis

Volumn 12, Issue 4, 2004, Pages 324-331

  Wei, Que King ^a   Jone, Wang W ^b   Fang, Tony J ^b  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

GM soybean; Isoflavones; Non GM soybean

Indexed keywords

ACETYLDAIDZIN; ACETYLGENISTIN; ACETYLGLYCITIN; DAIDZEIN; DAIDZIN; GENISTEIN; GENISTIN; GLYCITEIN; GLYCITIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; GENETICALLY MODIFIED CROP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; NONHUMAN; PH; PHASE SEPARATION; QUANTITATIVE ANALYSIS; SOYBEAN; TAIWAN;

EID: 14244265805     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wang, H. and Murphy, P. A. 1996. Mass balance study of isoflavones during soybean processing. J. Agric. Food Chem. 44: 2377-2383.
2. Rowland, I., Faughnan, M., Hoey, L., Wahala, K., Williamson, G. and Cassidy, A. 2003. Bioavailability of phyto-oestrogens. Br. J. Nutr. 89: 45-58.
3. Messina, M. J. and Barnes, S. 1991. The role of soy products in reducing cancer risk. J. Natl. Cancer Inst. 83: 541-546.
4. Tsai, S. J., Wahala, K. J., Murphy, P. A. and Hendrich, S. 1996. A diet high in wheat fiber decreases the bioavailability of soy bean isoflavones in a single meal fet to women. J. Nutr. 126: 871-877.
5. Anderson, J. J. B. and Ganer, S. C. 1997. Phytoestrogens and human function. Nutr. Today 32: 232-239.
6. Messina, M. J., Persky, V., Setchell, J. D. R. and Barnes, S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21: 113-131.
7. Adlercreutz, H., Bannwart, C., Wahala, K., Makela, T., Brunow, G., Hase, T., Arosemena, P. J., Kellis, J. T. and Bickery, L. E. 1995. Inhibition of human aromatease by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol. 44: 147-153.
8. Messina, M. J. 2003. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr. Rev. 61: 117-31.
9. Setchell, K. D. and Cassidy, A. 1999. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129: 758S-67S.
10. Wang, H. and Murphy, P. A. 1994. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop, years, and location. J. Agric. Food Chem. 42: 1674-1677.
11. King, R. A. and Bignell, C. M. 2000. Concentration of isoflavone phytoestrogens and their glucosides in Australian soya beans soya foods. Austral. J. Nutri. Diet. 57: 70-78.
12. Choi, Y. S., Lee, B. H., Kim, J. H. and Kim, N. S. 2000. Concentration of phytoestrogens in soybeans and soybean products in Kroea. J. Sci. Food Agric. 80: 1709-1712.
13. Simonne, A. H., Smith, M., Weaver, D. B., Vail, T., Barnes, S. and Wei, C. I. 2000. Retention and change of soy isoflavones and carotenoids in immature soybean seeds (Edamame) during processing. Agric. Food Chem. 48: 6061-6069.
14. Chunyang, W., Sherrard, M., Sherrard, M., Sudhakar, P., Wixon, R. and Scott, R. A. 2000. Isoflavone content among maturity group 0 to II soybeans. J. Amer. Oil Chem. Soci. 77: 483-486.
15. Hoeck, J. A., Fehr, W. R., Murphy, P. A. and Welke, G. A. 2000. Influence of genotype and environment on isoflavone contents of soybean. Crop Sci. 40: 48-51.
16. Wang, C. E. and Liu, X. Y. 1998. Composition, concentration and properties of soybean isoflavone. Food Sci. (Taiwan) 19: 39-43.
17. Wen, D. C., Chieh, J. S. and Yan, H. C. 2001. Optimization of acid hydrolysis conditions for total isoflavones analysis in soybean bypocotyls by using RSM. Food Chem. 72: 499-503.
18. Matsurra, M., Obata, A. and Fukushima, D. 1989. Objectionable flavor of soy mild developed during the soaking of soybeans and its contol. J. Food Sci. 54: 602-605.
19. Matuura, M. and Obata, A. 1993. β-glucosidase from soybeans hydrolyze daidzein and genistin. J. Food Sci. 58: 144-147.
20. Chiou, R. Y. Y. and Cheng, S. L. 2001. Isoflavones transformation during soybean koji preparation and subsequent miso fermentation supplemented with ethanol and MaCl. J. Agric. Food Chem. 49: 3656-3660.
21. Kao, C. H. 1997. The effects of processing conditions on the content of isoflavones in soy products and the effects of isoflavones on DNA damage in mammal cell by single cell gel electrophoresis. Master thesis. Taichung.
22. Hautabarat, L. S., Mulholland, M. and Hreenfield, H. 1998. Development and validation of an isocratic high-performance liquid chromatographic method for quantitative determination of phytoestrogens in soya bean. J. Chromatorg. 795: 377-382.
23. SAS Institute. 1996. SAS User's Guide Basics. 5th ed. SAS Institute. Cary, NC, U. S. A.
24. Ekdridge, A. C. and Kwolke, W. F. 1983. Soybean isoflavones: effect of environment and variety on composition. J. Agric. Food Chem. 31: 394-396.
25. Farmakalidis, E. and Murphy, P. A. 1985. Isolation of 6′- O-acetylgenistin and 6″-O-acetyldaidzin from toasted defatted soyflakes. J. Agric Food Chem. 33: 385-389.
26. Wang, H. J., Kuan, S., Francis, O. J., Ware, G. M. and Carman, A. S. 1990. A simplified HPLC method for the determination of phytoestrogens in soybean and its processed products. J. Agric. Food Chem. 38: 185-190.
27. Chiang, W. D., Shih, C. J. and Chu, Y. H. 2001. Optimization of acid hydrolysis conditions for total isoflavones analysis in soybean hypocotyls by using RSM. Food Chem. 499-503.
28. Welling, P. G. 1986. First-pass metabolism, enterophepatic circulation, and physicochemical factors affecting absorption. In "Pharmacokinetics- Processes and Mathematics". pp. 35-44. Welling, P. G., ed. American Chemical Society. Washington, DC, U. S. A.
29. Xu, X., Harris, K., Wang, H. J., Murphy, P. A. and Hendrich, S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125: 2307-2315.
30. Brown, J. P. 1988. Hydrolysis of glycosides and esters. In "Role of the Gut Flora in Toxicity and Cancer". pp.109-144. Towland, I. R., ed. Academic Press. San Diego, CA, U. S. A.
31. Barnes. S., Peterson, T. G. and Coward, L. 1995. Rationale for the use of genistein-containing soy matrixes tumors. Nutr. Cancer. 14: 103-10.